InsidersTradesSigma
Track the MaxCyte Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United Kingdom. Shares trade on the UK market, under the supervision of RNS (LSE). The latest transaction was reported on 31 January 2024 (Exercise). Among the most active insiders: John Johnston. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
MaxCyte Inc. is a company specializing in gene and cell transfer technologies. It develops solutions for research and cell therapy.